List of Studies ( Metabolite:TG 18:1_20:1_20:3)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004167 | AN006917 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST004118 | AN006828 | Lipidomics on Hep3B Cells Overexpressing CGI-158 and PNPLA2 | Cultured cells | Human | Liver disease; Cancer | Amgen | LC-MS |
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003758 | AN006170 | Untargeted lipidomics of gemcitabine-resistant cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003703 | AN006075 | NAD Depletion in Skeletal Muscle does not Compromise Muscle Function or Accelerate Aging | Muscle | Mouse | Sarcopenia | University of Copenhagen | LC-MS |
| ST003629 | AN005962 | Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells | T-cells | Human | Brain disease | Leibniz Institute for Plasma Science and Technology | LC-MS |
| ST003528 | AN005795 | Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma | Liver | Mouse | Cancer | University of Utah | LC-MS |
| ST001336 | AN002230 | Effect of high-fat diet and bile acid treatment on serum and tissue lipidomes in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | LC-MS | |
| ST001111 | AN001805 | Breast Cancer Lipidomics Tissue | Adipose tissue | Human | Cancer | Baylor College of Medicine | LC-MS |
